102 results
Page 2 of 6
8-K
EX-99.1
2ka2d erby
1 Oct 20
Contingent Value Rights Agreement
8:42am
8-K
EX-10.1
ud3lku ze8
10 Sep 20
Entry into a Material Definitive Agreement
4:43pm
8-K
EX-10.4
j6r562zgjob6kinw6k
10 Sep 20
Entry into a Material Definitive Agreement
4:43pm
8-K
EX-10.2
f911er65dndv1k2si du
10 Sep 20
Entry into a Material Definitive Agreement
4:43pm
SC TO-C
EX-99.2
281nhe463 kl1igplra
10 Aug 20
Information about tender offer
9:50pm
8-K
EX-99.2
l0jep
10 Aug 20
Tender and Support Agreement
9:48pm
8-K
EX-99.1
ajjkcd6 bj360r7zv
6 May 20
Ligand Reports First Quarter 2020 Financial Results
4:03pm
8-K
EX-99.1
wcs jq0dqalfzy9md
2 Apr 20
Ligand Completes Acquisition of Icagen Core Assets, Partnered Programs
4:18pm
8-K
EX-99.1
olw6ze pn
5 Mar 19
Entry into a Material Definitive Agreement
5:16pm
8-K
vcs9slw 2m4q
5 Mar 19
Entry into a Material Definitive Agreement
5:16pm